MedCap AB (Sweden) Buy Hold or Sell Recommendation
| MCAP Stock | SEK 373.50 12.50 3.46% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding MedCap AB is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell MedCap AB given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for MedCap AB, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out MedCap AB Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as MedCap and provide practical buy, sell, or hold advice based on investors' constraints. MedCap AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
MedCap |
Execute MedCap AB Buy or Sell Advice
The MedCap recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on MedCap AB. Macroaxis does not own or have any residual interests in MedCap AB or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute MedCap AB's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves slightly opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
MedCap AB Trading Alerts and Improvement Suggestions
| MedCap AB generated a negative expected return over the last 90 days | |
| MedCap AB has high historical volatility and very poor performance | |
| MedCap AB has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| About 30.0% of the company outstanding shares are owned by corporate insiders |
MedCap AB Returns Distribution Density
The distribution of MedCap AB's historical returns is an attempt to chart the uncertainty of MedCap AB's future price movements. The chart of the probability distribution of MedCap AB daily returns describes the distribution of returns around its average expected value. We use MedCap AB price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of MedCap AB returns is essential to provide solid investment advice for MedCap AB.
| Mean Return | -0.55 | Value At Risk | -4.19 | Potential Upside | 2.80 | Standard Deviation | 4.37 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of MedCap AB historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
MedCap AB Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to MedCap AB or Financial Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that MedCap AB's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a MedCap stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.63 | |
β | Beta against Dow Jones | -0.62 | |
σ | Overall volatility | 4.53 | |
Ir | Information ratio | -0.1 |
MedCap AB Volatility Alert
MedCap AB exhibits very low volatility with skewness of -4.68 and kurtosis of 32.26. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure MedCap AB's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact MedCap AB's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.MedCap AB Fundamentals Vs Peers
Comparing MedCap AB's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze MedCap AB's direct or indirect competition across all of the common fundamentals between MedCap AB and the related equities. This way, we can detect undervalued stocks with similar characteristics as MedCap AB or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of MedCap AB's fundamental indicators could also be used in its relative valuation, which is a method of valuing MedCap AB by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare MedCap AB to competition |
| Fundamentals | MedCap AB | Peer Average |
| Return On Equity | 0.15 | -0.31 |
| Return On Asset | 0.0822 | -0.14 |
| Profit Margin | 0.10 % | (1.27) % |
| Operating Margin | 0.15 % | (5.51) % |
| Current Valuation | 3.15 B | 16.62 B |
| Shares Outstanding | 14.81 M | 571.82 M |
| Shares Owned By Insiders | 30.17 % | 10.09 % |
| Shares Owned By Institutions | 40.93 % | 39.21 % |
| Price To Earning | 197.02 X | 28.72 X |
| Price To Book | 3.83 X | 9.51 X |
| Price To Sales | 2.95 X | 11.42 X |
| Revenue | 916.3 M | 9.43 B |
| Gross Profit | 707.3 M | 27.38 B |
| EBITDA | 200.3 M | 3.9 B |
| Net Income | 96.5 M | 570.98 M |
| Cash And Equivalents | 139.7 M | 2.7 B |
| Cash Per Share | 1.17 X | 5.01 X |
| Total Debt | 165.4 M | 5.32 B |
| Debt To Equity | 102.00 % | 48.70 % |
| Current Ratio | 1.00 X | 2.16 X |
| Book Value Per Share | 57.83 X | 1.93 K |
| Cash Flow From Operations | 116.3 M | 971.22 M |
| Earnings Per Share | 7.98 X | 3.12 X |
| Number Of Employees | 3 | 18.84 K |
| Beta | 0.65 | -0.15 |
| Market Capitalization | 3.57 B | 19.03 B |
| Total Asset | 1.17 B | 29.47 B |
| Working Capital | 141 M | 1.48 B |
| Current Asset | 392 M | 9.34 B |
| Current Liabilities | 251 M | 7.9 B |
| Z Score | 12.6 | 8.72 |
| Net Asset | 1.17 B |
MedCap AB Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as MedCap . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About MedCap AB Buy or Sell Advice
When is the right time to buy or sell MedCap AB? Buying financial instruments such as MedCap Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having MedCap AB in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Financials ETFs Thematic Idea Now
Financials ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Financials ETFs theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for MedCap Stock Analysis
When running MedCap AB's price analysis, check to measure MedCap AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedCap AB is operating at the current time. Most of MedCap AB's value examination focuses on studying past and present price action to predict the probability of MedCap AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedCap AB's price. Additionally, you may evaluate how the addition of MedCap AB to your portfolios can decrease your overall portfolio volatility.